Uday Kompella
Chief Scientific Officer
About
Key Areas of Interest: Nanotechnology for drug delivery, gene delivery, and imaging; Ocular, nasal, and pulmonary delivery; Supercritical fluid technology for delivery systems; Anti-angiogenic and anti-inflammatory therapeutics for diabetic retinopathy, age related macular degeneration, corneal angiogenesis, and cancers.
United States
Denver
Pharmaceuticals
Pharmacokinetics, Drug Delivery, Pharmaceutics, Ophthalmology, Drug Discovery, Biotechnology, Nanotechnology, Pharmacology, Pharmaceutical Industry, Formulation, Drug Development, Technology Transfer, Clinical Development, Protein Chemistry, Life Sciences, Supercritical Fluids
Experience
Chief Scientific Officer
EyeTrans Technologies, Inc.
New York, NY
Professor of Pharmaceutics & Ophthalmology
University of Colorado at Denver and Health Sciences Center
Chief Scientific Officer
Ocugen, Inc.
Aurora, CO; Malvern, PA
Education
University of Southern California
Pharmaceutical Sciences
Uday Kompella's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles
Find Emails
Access verified email addresses for your target contacts.
657M+ emails
Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers
More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.